Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;20(3 Neurology of Systemic Disease):670-80.
doi: 10.1212/01.CON.0000450973.84075.a7.

Neurologic manifestations of acute and chronic liver disease

Review

Neurologic manifestations of acute and chronic liver disease

Halina White. Continuum (Minneap Minn). 2014 Jun.

Abstract

Purpose of review: This article summarizes the most common neurologic sequelae of acute and chronic liver failure, liver transplantation, and other treatments for liver disease, and outlines the pathogenesis, neurologic manifestations, and treatment of Wilson disease.

Recent findings: The neurologic manifestations of liver disease are caused by the liver's failure to detoxify active compounds that have deleterious effects on the central and peripheral nervous systems. In addition, treatments for liver disease such as liver transplantation, transjugular intrahepatic portosystemic shunt, and antiviral medications can also be neurotoxic. Wilson disease affects the liver and nervous system simultaneously and may often initially be diagnosed by a neurologist; treatment options have evolved over recent years.

Summary: Acute and chronic liver diseases are encountered commonly in the general population. Neurologic dysfunction will eventually affect a significant number of these individuals, especially if the disease progresses to liver failure. Early recognition of these neurologic manifestations can lead to more effective management of these patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Younossi ZM,, Stepanova M,, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9 (6): 524–530.e1. - PubMed
    1. Bernal W,, Auzinger G,, Dhawan A,, Wendon J. Acute liver failure. Lancet 2010; 376 (9736): 190–201. - PubMed
    1. D’Amico G,, Garcia-Tsao G,, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (1): 217–231. - PubMed
    1. Loftis JM,, Matthews AM,, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 2006; 66 (2): 155–174. - PubMed
    1. Hosoda S,, Takimura H,, Shibayama M, et al. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci 2000; 54 (5): 565–572. - PubMed